tiprankstipranks

HealthStream price target raised to $26 from $23 at Canaccord

Canaccord analyst Richard Close raised the firm’s price target on HealthStream to $26 from $23 and keeps a Hold rating on the shares. The analyst noted they reported a quarter that beat both our revenue and adjusted-EBITDA estimates and 2023 initial guidance was mixed with revenue growth of 4-6% estimate but missing consensus but adjusted-EBITDA above our prior forecast.

Protect Your Portfolio Against Market Uncertainty

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on HSTM:

Disclaimer & DisclosureReport an Issue